Histologically defined biomarkers in toxicology

Bibliography

• EZZELL C: The price of pills. Does it really take $897 million for a new therapy? Sci. Am. (2003) 289(1):25.
   PubMedGoogle Scholar
• DE JONG PE, NYNKE HALBESMA N, GANSEVOORT RT: Screening for early chronic kidney disease – what method fits best? Nephrol. Dial. Transplant. (2006) 21(9):2358-2361.
   PubMed Web of Science ®Google Scholar
• CLAMPITT RB, HART RJ: The tissue activities of some diagnostic enzymes in some mammalian species. J. Comp Pathol. (1978) 88:607-621.
   PubMed Web of Science ®Google Scholar
• KOH E, NAKAMURA T, TAKAHASHI H: Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats. Circ. J. (2004) 68(2):163-167.
   PubMed Web of Science ®Google Scholar
• AUNER HW, TINCHON C, LINKESCH W et al.: Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies. Ann. Hematol. (2003) 82(4):218-222.
   PubMed Web of Science ®Google Scholar
• HERMAN EH, ZHANG J, RIFAI N et al.: The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother. Pharmacol. (2001) 48(4):297-304.
   PubMed Web of Science ®Google Scholar
• KATIRJ B, AL JAHERI MM: Creatinine kinase revisited. J. Neuromusc. Dis. (2001) 2:158-163.
   PubMedGoogle Scholar
• SPARANO JA, BROWN DL, WOLFF AC: Predicting cancer therapy-induced cardiotoxicity: the role of troponin and other markers. Drug Saf. (2002) 25(5):301-311.
   PubMed Web of Science ®Google Scholar
• SPECCHIA G, BUQUICCHIO C, PANSINI N et al.: Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. J. Lab. Clin. Med. (2005) 145(4):212-220.
   PubMed Web of Science ®Google Scholar
• HERMAN EH, ZHANG J, LIPSHULTZ SE et al.: Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J. Clin. Oncol. (1999) 17(7):2237-2243.
   PubMed Web of Science ®Google Scholar
• WALLACE KB, HAUSNER E, HERMAN E et al.: Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol. Pathol. (2004) 32:106-121.
   PubMed Web of Science ®Google Scholar
• ARSALANE K, BROECKAERT F, KNOOPS B et al.: Increased serum and urinary concentrations of lung Clara cell protein in rats acutely exposed to ozone. Toxicol. Appl. Pharmacol. (1999) 159(3):169-174.
   PubMed Web of Science ®Google Scholar
• BERNARD A, CARBONNELLE S, NICKMILDER M, DE BURBURE C: Non-invasive biomarkers of pulmonary damage and inflammation: application to children exposed to ozone and trichloramine. Toxicol. Appl. Pharmacol. (2005) 206(2):185-190.
   PubMed Web of Science ®Google Scholar
• BALLET F: Hepatotoxicity in drug development: detection, significance and solutions. J. Hepatol. (1997) 26(Suppl. 2):26-36.
   PubMed Web of Science ®Google Scholar
• TRULL AK, FACEY SP, REES GW et al.: Serum α-glutathione S-transferase: a sensitive marker of hepatocellular damage associated with liver allograft rejection. Transplantation (1994) 58:1345-1351.
   PubMed Web of Science ®Google Scholar
• GIFFEN PS, PICK CR, PRICE MA, WILLIAMS A, YORK M: Alpha-glutathione S-transferase in the assessment of hepatotoxicity – its diagnostic utility in comparison with other recognized markers in the Wistar Han rat. Toxicol. Pathol. (2002) 30(3):365-372.
   PubMed Web of Science ®Google Scholar
• O’BRIEN PJ, SLAUGHTER MR, POLLEY SR, KRAMER K: Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab. Anim. (2002) 36(3):313-321.
   PubMed Web of Science ®Google Scholar
• WOODMAN DD: Assessment of hepatotoxicity. In: Animal Clinical Chemistry, a primer for toxicologists. Evans GO (Ed.), Taylor & Francis Publishers, UK (1996):71-86.
   Google Scholar
• SCHMIDT ES, SCHMIDT FW: Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme. Clin. Chim. Acta. (1988) 43:43-56.
   Google Scholar
• SONI MG, MANGIPUDY RS, MUMTAZ MM, MEHENDALE HM: Tissue repair response as a function of dose during trichloroethylene hepatotoxicity. Toxicol. Sci. (1998) 42(2):158-165.
   PubMed Web of Science ®Google Scholar
• SHAW M: The use of histologically defined specific biomarkers in drug development with special reference to the glutathione S-transferases. Cancer Biomark. (2005) 1:69-74.
   PubMedGoogle Scholar
• BECKETT GJ, HAYES JD: Glutathione S-transferase measurements and liver disease in man. J. Clin. Biochem. Nutr. (1987) 2:1-24.
   Web of Science ®Google Scholar
• REES GR, TRULL AK, DOYLE S: Evaluation of an enzyme immunometric assay for serum α-glutathione S-transferase. Ann. Clin. Biochem. (1995) 32:575-583.
   PubMed Web of Science ®Google Scholar
• BORAN M, ÇETIN S: The role of α glutathione S-transferase in the monitoring of hemodialysis patients with hepatitis C infection undergoing high dose Interferon α-2b therapy. Nephron (1995) 82:22-26.
   Google Scholar
• COLUCCIO D, NICKLAUS R, SCHNEIDER S, LEWIS M, HALL L: A study to evaluate biotrin rat alpha-glutathione S-transferases (alpha-GST) enzyme immunoassay (EIA) and its value to detect liver changes compared to standard liver enzymes, American Association of Clinical Chemists. 52nd Annual Meeting, San Francisco, CA, USA. Clin. Chem. (2000) 46:A140.
   Google Scholar
• SUNDBERG AGM, NILSON R, APPELKVIST A-L, DALLNER G: Immunohistochemical localisation of alpha and pi class glutathione S-transferases in normal human tissues. Pharmacol. Toxicol. (1993) 72:321-331.
   PubMedGoogle Scholar
• TEE LBG, GILMORE KS, MEYER DG et al.: Expression of glutathione S-transferase during rat liver development. Biochem. J. (1992) 282:209-218.
   PubMed Web of Science ®Google Scholar
• MULLER W, MOHR S, ZUHLKE U et al.: Alpha glutathione S transferase as biomarker for liver injury in cynomolgus monkeys – validation of a human assay. Poster presented at: The American Society of Toxicology Meeting. 25 – 29 March, San Francisco, California, USA (2001).
   Google Scholar
• COCKERALL GL, MCKIM JM Jr, VONDERFECHT SL: Strategic importance of research support through pathology. Toxicol. Pathol. (2002) 30(1):4-7.
   PubMed Web of Science ®Google Scholar
• CLARKE H, EGAN DA, HEFFERNAN M et al.: α-Glutathione S-transferase (αGST) release, an early indicator of carbon tetrachloride hepatotoxicity in the rat. Hum. Exp. Toxicol. (1997) 16:154-157.
   PubMed Web of Science ®Google Scholar
• EASON S, MANGHANI M, GREIG G, MERZ M: Serum glutathione S-transferase alpha (αGST): a suitable biomarker for drug related liver injury? Poster presented at: The 8th World congress on clinical pharmacology and therapeutics. Brisbane, Australia (2004).
   Google Scholar
• SIVILOTTI MLA, BIRD SB, MONTALVO M ET AL.: Serum α-glutathione S-transferase (αGST) becomes elevated shortly after subtoxic Acetaminophen overdose. Poster presented at: The Society for Academic Emergency Medicine Annual Meeting. St Louis, MO, USA (2002).
   Google Scholar
• MAXWELL PR, SHAW M, MENDONCA C, BURDEN RD: Serum alpha glutathione S-transferase as a biomarker of methotrexate induced hepatotoxicity. Poster presented at: The 43rd annual meeting of the Society of Toxicology. Baltimore, USA (2004).
   Google Scholar
• OHATA H, MOMOSE K, TAKAHASHI A, OMORI Y: Urinalysis for detection of chemically induced renal damage (1) – changes in urinary excretions of enzymes and various components caused by mercuric chloride and gentamicin. J. Toxicol. Sci. (1987) 12(4):341-355.
   PubMedGoogle Scholar
• OHATA H, MOMOSE K, TAKAHASHI A OMORI Y: Urinalysis for detection of chemically induced renal damage (2) – changes in urinary excretions of enzymes and various components caused by p-aminophenol, puromycin aminonucleoside and hexadimethrine. J. Toxicol. Sci. (1987) 12(4):357-372.
   PubMedGoogle Scholar
• STONARD MD: Assessment of nephrotoxicity. In: Animal Clinical Chemistry, a primer for toxicologists. Evans GO (Ed.), Taylor & Francis Publishers, UK (1996):87-98.
   Google Scholar
• BOSOMWORTH MP, APARICIO SR, HAY WHM: Urine N-acetyl-β-d-glucosamidase – a biomarker of tubular damage? (1999) Nephrol. Dial. Transplant. 14:620-626.
   PubMed Web of Science ®Google Scholar
• HARRISON DJ, KHARBANDA R, CUNNINGHAM DS, MCCLELLAN LI, HAYES JD: Glutathione S-transferase isoenzymes in the human kidney: basis for possible markers of renal injury. J. Clin Pathol. (1989) 42:624-629.
   PubMed Web of Science ®Google Scholar
• ROZELL B, HANSSON HA, GUTHENBERG C, TAHIR MK, MANNERVIK B: Glutathione transferases of classes alpha, mu and pi show selective expression in different regions of rat kidney. Xenobiotica (1993) 23(8):835-849.
   PubMed Web of Science ®Google Scholar
• SUNDBERG AGM, APPELKVIST E-L, BÄCKMAN L, DALLNER G: Quantitation of glutathione S-transferase-pi in the urine by radioimmunoassay. Nephron (1994) 66:162-169.
   PubMedGoogle Scholar
• KHARASCH ED, HOFFMAN GM, THORNING D, HANKINS DC, KILTY CG: Role of renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology (1998) 88(6):1624-1633.
   PubMed Web of Science ®Google Scholar
• GOLDBERG ME, CANTILLO J, GRATZ I et al.: Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in volunteers. Anesth. Analg. (1999) 88:437-445.
   PubMed Web of Science ®Google Scholar
• OKAMOTO K, COLLETTE W III, MONDAL M, DE PEYSTER A, STEVENS GJ: Evaluation of kidney toxicity detection methods in rat urine: GSTs by α and µGST enzyme immunoassays, metabolite profiling by NMR, and protein profiling by SELDI-TOF-MS. Poster presented at: The 44th annual meeting of the Society of Toxicology. New Orleans, USA (2005).
   Google Scholar
• DAVIES D, BRADSHAW J, COOPE M, WESTWOOD R, KNIGHT R, MURFIN K: Novel biomarkers for the detection of regional kidney damage in the rat. Poster presented at: The EMBODY Meeting. Cambridge, UK (2000).
   Google Scholar
• PAI MP, NORENBERG JP, TELEPAK RA, SIDNEY DS, YANG S: Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate. Antimicrob. Agents Chemother. (2005) 49(9):3784-3788.
   PubMed Web of Science ®Google Scholar
• MAXWELL PR, GORDON D, COYLE A: Differentiation between renal injury and compensatory responses by the use of specific biomarkers. Poster presented at: The 43rd annual meeting of the Society of Toxicology. Baltimore, USA (2004).
   Google Scholar
• FALKENBERG F, HILDEBRAND H, LUTTE L et al.: Urinary antigens as markers of papillary toxicity. I. Identification and characterization of rat kidney papillary antigens with monoclonal antibodies. Arch. Toxicol. (1996) 71:80-92.
   PubMed Web of Science ®Google Scholar
• HILDEBRAND H, RINKE M, SCHLÜTER G, BOMHARD E, FALKENBERG FW: Urinary antigens as markers of papillary toxicity. II Application of monoclonal antibodies for the determination of papillary antigens in rat urine. Arch. Toxicol. (1999) 73:233-245.
   PubMed Web of Science ®Google Scholar